Lei Zheng

33.6k citations
430 papers · 13.7k indexed · 5 hit papers · h-index 58

Lei Zheng

409 papers receiving 13.5k citations

Hit Papers

Synthetic biology‐based...592019202620212023100200300400

Peers

Lei Zheng
Comparison fields: 5 of 161
  • Cancer Research 3.9k
  • Molecular Biology 7.9k
  • Biomedical Engineering 2.5k
  • Immunology 1.2k
  • Genetics 564
Replace Debabrata Mukhopadhyay with:
Debabrata Mukhopadhyay United States
Meng Zhang China
Jing Liu China
Michael Hsiao Taiwan
Siu Kwan Sze Singapore
Jie Li China
Peifeng Li China
Wei Duan China
Suzy V. Torti United States
Jinmin Zhao China
Lei Zheng relative to Debabrata Mukhopadhyay United States Debabrata Mukhopadhyay's profile →
Citations per field
00.5×5.2×
Debabrata Mukhopadhyay · 1×
Citations per year

Countries citing papers authored by Lei Zheng

Since Specialization
Citations

This map shows the geographic impact of Lei Zheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Zheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Zheng more than expected).

Fields of papers citing papers by Lei Zheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lei Zheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Zheng. The network helps show where Lei Zheng may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Lei Zheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lei Zheng Line = papers co-authored together Lei Zheng links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20252
2 20252
3 20251
4 20250
5 20243
6 20244
7 202410
8 202310
9 20239
10 202311
11 202315
12 20236
13 20231
14 202326
15 20232
16 20227
17 202120
18 202086
19
Defining mesenchymal stromal cell (MSC)‐derived small extracellular vesicles for therapeutic applicationsbreakdown →
2019462
20 20104

About Lei Zheng

Lei Zheng is a scholar working on Cancer Research, Molecular Biology and Immunology, having authored 430 papers that have together received 13.7k indexed citations. Recurring topics across this work include Extracellular vesicles in disease (75 papers), Advanced biosensing and bioanalysis techniques (57 papers), MicroRNA in disease regulation (52 papers), Cancer-related molecular mechanisms research (40 papers), Nanoplatforms for cancer theranostics (35 papers), Biosensors and Analytical Detection (24 papers), Circular RNAs in diseases (21 papers) and Luminescence and Fluorescent Materials (18 papers). The work is most often cited by research in Cancer Research (3.9k citations), Molecular Biology (7.9k citations) and Biomedical Engineering (2.5k citations). Lei Zheng has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yan‐Wei Hu, Bo Situ, Qian Wang, Bo Li, Taixue An, Yiyao Huang, Qian Wang, Weilun Pan, Hang Zou and Sihua Qin. Their work appears in journals such as Journal of the American Chemical Society, Chemical Society Reviews and Advanced Materials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026